Ogundaini A et al. |
Isolation of two new antiinflammatory biflavanoids from Sarcophyte piriei. |
1996 |
J. Nat. Prod. |
pmid:8786365
|
Baker RR |
Enzymes of platelet activating factor synthesis in brain. |
1995 |
Neurochem. Res. |
pmid:8786821
|
Yoshii H et al. |
Neurotropin inhibits accumulation of eosinophils induced by allergen through the suppression of sensitized T-cells. |
1995 |
Int. J. Immunopharmacol. |
pmid:8788117
|
Battye KM et al. |
Ovine endometrium synthesizes and releases platelet-activating factor, which can cause the release of prostaglandin F2 alpha by the uterus in situ. |
1996 |
Biol. Reprod. |
pmid:8788186
|
Hirafuji M et al. |
Involvement of platelet cyclic GMP but not cyclic AMP suppression in leukocyte-dependent platelet adhesion to endothelial cells induced by platelet-activating factor in vitro. |
1996 |
Br. J. Pharmacol. |
pmid:8789382
|
Bazan NG and Allan G |
Platelet-activating factor is both a modulator of synaptic function and a mediator of cerebral injury and inflammation. |
1996 |
Adv Neurol |
pmid:8790822
|
Naraba H et al. |
Inhibitory effect of arachidonic acid on platelet-activating factor production in rat neutrophils. |
1996 |
Eur. J. Pharmacol. |
pmid:8790999
|
Aïssa J et al. |
Biochemical and cellular effects of heparin-protamine injection in rabbits are partially inhibited by a PAF-acether receptor antagonist. |
1996 |
Eur. J. Pharmacol. |
pmid:8791000
|
Weikert LF and Bernard GR |
Pharmacotherapy of sepsis. |
1996 |
Clin. Chest Med. |
pmid:8792067
|
Takeda H et al. |
Release of fructose and hexose phosphates from perivascular cells induced by low density lipoprotein and acceleration of protein glycation in vitro. |
1996 |
Diabetes Res. Clin. Pract. |
pmid:8792096
|
Abebe W et al. |
Platelet-activating factor-induced inositol 1,4,5-trisphosphate generation in undifferentiated and differentiated U937 cells: role of tyrosine kinase. |
1996 |
Int. J. Immunopharmacol. |
pmid:8796445
|
Parent JL et al. |
Identification of transmembrane domain residues determinant in the structure-function relationship of the human platelet-activating factor receptor by site-directed mutagenesis. |
1996 |
J. Biol. Chem. |
pmid:8798529
|
Marcheselli VL and Bazan NG |
Sustained induction of prostaglandin endoperoxide synthase-2 by seizures in hippocampus. Inhibition by a platelet-activating factor antagonist. |
1996 |
J. Biol. Chem. |
pmid:8798751
|
van Rossem K et al. |
The role of PAF and the effect of a specific PAF antagonist on local tissue PO2 and neuronal integrity during and after photothrombotic brain infarction in unanesthetised rabbits. |
1996 |
Adv. Exp. Med. Biol. |
pmid:8798843
|
Westmoreland SV et al. |
Toxicity of TNF alpha and platelet activating factor for human NT2N neurons: a tissue culture model for human immunodeficiency virus dementia. |
1996 |
J. Neurovirol. |
pmid:8799203
|
Civelli M et al. |
The involvement of the release of nitric oxide in the pharmacological activity of the new furoxan derivative CHF 2363. |
1996 |
Br. J. Pharmacol. |
pmid:8799563
|
Noguchi K et al. |
Involvement of nitric oxide and eicosanoids in platelet-activating factor-induced haemodynamic and haematological effects in dogs. |
1996 |
Br. J. Pharmacol. |
pmid:8799566
|
Marrakchi N et al. |
[Biochemical and pharmacologic properties of platelet aggregants and platelet antiaggregants of viper venoms in Tunisia]. |
1994 Jul-Oct |
Arch Inst Pasteur Tunis |
pmid:8801850
|
Catalán RE et al. |
Nitric oxide mediates the PAF-stimulated cyclic GMP production in hippocampal slices. |
1996 |
Biochem. Biophys. Res. Commun. |
pmid:8806587
|
Baskin SI et al. |
The effects of EDRF/NO releasers or calcium ionophore A23187 on cyanide toxicity in mice. |
1996 |
Toxicol. Appl. Pharmacol. |
pmid:8806852
|
Dunlop ME et al. |
Production of hyaluronan by glomerular mesangial cells in response to fibronectin and platelet-derived growth factor. |
1996 |
Kidney Int. |
pmid:8807570
|
Arima S et al. |
Platelet-activating factor dilates efferent arterioles through glomerulus-derived nitric oxide. |
1996 |
J. Am. Soc. Nephrol. |
pmid:8808114
|
Tachibana F et al. |
Platelet-activating factor and leukotrienes in acute otitis media, secretory otitis media, and chronic otitis media on the acute excerbation. |
1996 |
Auris Nasus Larynx |
pmid:8809319
|
Yasugahira H et al. |
[The changes of blood gas analysis values and platelet aggregability on acute phase in the experimental model of pulmonary embolism prepared by sephadex G-75 (SG-75) injection]. |
1996 |
Nihon Kyobu Shikkan Gakkai Zasshi |
pmid:8810754
|
Durán WN et al. |
Platelet-activating factor modulates leukocyte adhesion to endothelium in ischemia-reperfusion. |
1996 |
Microvasc. Res. |
pmid:8812764
|
Tao Y et al. |
Platelet-activating factor enhances urokinase-type plasminogen activator gene expression in corneal epithelium. |
1996 |
Invest. Ophthalmol. Vis. Sci. |
pmid:8814143
|
Erger RA and Casale TB |
Eosinophil migration in response to three molecular species of platelet activating factor. |
1996 |
Inflamm. Res. |
pmid:8814455
|
Sato E et al. |
Bradykinin stimulates alveolar macrophages to release neutrophil, monocyte, and eosinophil chemotactic activity. |
1996 |
J. Immunol. |
pmid:8816423
|
Bauldry SA and Wooten RE |
Leukotriene B4 and platelet activating factor production in permeabilized human neutrophils: role of cytosolic PLA2 in LTB4 and PAF generation. |
1996 |
Biochim. Biophys. Acta |
pmid:8816854
|
Le Texier L et al. |
Structure-activity relationships in platelet-activating factor (PAF). 7. Tetrahydrofuran derivatives as dual PAF antagonists and acetylcholinesterase inhibitors. Synthesis and PAF-antagonistic activity. |
1996 |
J Lipid Mediat Cell Signal |
pmid:8816984
|
Le Texier L et al. |
Structure-activity relationships in platelet-activating factor (PAF). 8. Tetrahydrofuran derivatives as dual PAF antagonists and acetylcholinesterase inhibitors: anti-acetylcholinesterase activity and comparative SAR. |
1996 |
J Lipid Mediat Cell Signal |
pmid:8816985
|
Le Solleu H et al. |
A pharmacophore for high affinity PAF antagonists. I. Electronic model using molecular electrostatic potential. |
1996 |
J Lipid Mediat Cell Signal |
pmid:8816988
|
Abu-Zidan FM and Walther S |
Platelet activating factor antagonism improves cardiovascular function in non-hypotensive sepsis in pigs. |
1996 |
Eur J Surg |
pmid:8817228
|
Lin J et al. |
Effects of platelet-activating factor (PAF) receptor blockage on mucous glycoprotein secretion in cultured chinchilla middle ear epithelium. |
1996 |
Acta Otolaryngol. |
pmid:8820353
|
Kuitert L and Barnes NC |
PAF and asthma--time for an appraisal? |
1995 |
Clin. Exp. Allergy |
pmid:8821294
|
Miguélez R et al. |
Anti-inflammatory effect of a PAF receptor antagonist and a new molecule with antiproteinase activity in an experimental model of acute urate crystal arthritis. |
1996 |
J Lipid Mediat Cell Signal |
pmid:8821809
|
Murakami K et al. |
A novel platelet activating factor antagonist, SM-12502, attenuates endotoxin-induced disseminated intravascular coagulation and acute pulmonary vascular injury by inhibiting TNF production in rats. |
1996 |
Thromb. Haemost. |
pmid:8822594
|
Yang HO et al. |
Biological and pharmacological effects of pinusolide, a novel platelet activating factor antagonist. |
1995 |
Planta Med. |
pmid:8824945
|
Predescu D et al. |
The vascular distribution of the platelet-activating factor receptor. |
1996 |
Eur. J. Cell Biol. |
pmid:8825027
|
Burt RP et al. |
The role of diacylglycerol and activation of protein kinase C in alpha 1A-adrenoceptor-mediated contraction to noradrenaline of rat isolated epididymal vas deferens. |
1996 |
Br. J. Pharmacol. |
pmid:8825367
|
Grinyó JM et al. |
The role of platelet-activating factor antagonists in the prophylaxis of posttransplant acute tubular necrosis. |
1996 |
Ren Fail |
pmid:8827990
|
López-Novoa JM et al. |
The role of platelet-activating factor and the effect of PAF blocking receptors on the outcome of ARF. |
1996 |
Ren Fail |
pmid:8827995
|
Spangelo BL and Jarvis WD |
Lysophosphatidylcholine stimulates interleukin-6 release from rat anterior pituitary cells in vitro. |
1996 |
Endocrinology |
pmid:8828503
|
Galloway SW and Kingsnorth AN |
Lung injury in the microembolic model of acute pancreatitis and amelioration by lexipafant (BB-882), a platelet-activating factor antagonist. |
1996 |
Pancreas |
pmid:8829181
|
Sandoval D et al. |
The role of neutrophils and platelet-activating factor in mediating experimental pancreatitis. |
1996 |
Gastroenterology |
pmid:8831604
|
Ribaldi E et al. |
Inhibition of PAF synthesis by stimulated human polymorphonuclear leucocytes with cloricromene, an inhibitor of phospholipase A2 activation. |
1996 |
Br. J. Pharmacol. |
pmid:8832056
|
Savu SR et al. |
Determination of 1-O-acyl-2-acetyl-sn-glyceryl-3-phosphorylcholine, platelet-activating factor and related phospholipids in biological samples by high-performance liquid chromatography--tandem mass spectrometry. |
1996 |
J. Chromatogr. B, Biomed. Appl. |
pmid:8832423
|
Tsukioka K et al. |
Increased plasma level of platelet-activating factor (PAF) and decreased serum PAF acetylhydrolase (PAFAH) activity in adults with bronchial asthma. |
1996 Jan-Feb |
J Investig Allergol Clin Immunol |
pmid:8833165
|
Matsuo Y et al. |
Role of platelet-activating factor and thromboxane A2 in radical production during ischemia and reperfusion of the rat brain. |
1996 |
Brain Res. |
pmid:8833766
|
Gabryelewicz A |
Etiology and pathogenesis of acute pancreatitis--current view. |
1995 |
Rocz. Akad. Med. Bialymst. |
pmid:8834603
|